CME/CE

Conference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice

16:30

Faculty: Ravi Savarirayan, MBBS, MD Faculty: Julie Hoover-Fong, MD, PhD, FACMGG

In this expert discussion, Drs. Ravi Savarirayan and Julie Hoover-Fong examine how findings from the PROPEL 3 trial of oral infigratinib fit within the evolving treatment landscape for achondroplasia in children. They review the study's efficacy and safety results in the context of currently available therapies and…